Skip to Content
Merck
CN
  • Development and validation of an LC assay for sumatriptan succinate residues on surfaces in the manufacture of pharmaceuticals.

Development and validation of an LC assay for sumatriptan succinate residues on surfaces in the manufacture of pharmaceuticals.

Journal of pharmaceutical and biomedical analysis (2002-08-23)
María J Nozal, José L Bernal, L Toribio, María T Martín, Francisco J Diez
ABSTRACT

A high performance liquid chromatographic (HPLC) method for the assay of sumatriptan succinate residues in swabs collected from manufacturing equipment surfaces was developed and validated in order to control a cleaning procedure. The swabbing procedure using two cotton swabs moistened with water was validated applying a wipe-test and a HPLC method developed to determine low quantities of the drug. The HPLC method involves a C18 column at 25 degrees C, a mixture of ammonium phosphate monobasic (0.05 M)-acetonitrile (84:16, v/v) as a mobile phase and UV detection at 228 nm. Using the proposed method, the average recoveries obtained are of 88.5% for vinyl, 94.2% for glass and 95.2% for stainless steel plates with RSD of 5.5 (n=36), 2.3 (n=36), 2.2% (n=36), respectively. The method was successfully applied to the assay of real swab samples collected from the equipment surfaces.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ammonium phosphate monobasic, BioUltra, ≥99.5% (T)